Vendas +55 (81) 3231.0614 - contato@promepe.com.br

Inhibition of Restenosis in Femoropopliteal Arteries

Inhibition of Restenosis in Femoropopliteal Arteries Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial

In this pilot trial, paclitaxel balloon coating caused no obvious adverse events and reduced restenosis in atients undergoing angioplasty of femoropopliteal arteries.
12/09/2008

 

Veja também

IN.PACT ADMIRAL DRUG-COATED BALLOON OUTPERFORMS STANDARD ANGIOPLASTY IN LANDMARK STUDY When Not to Implant the Multilayer Flow Modulator: Lessons Learned From Application Outside the Indications for Use in Patients With Thoracoabdominal Pathologies Estudo do balão farmacológico Pacific In.pact Multilayer Stent Drug-Eluting Ballons in the SFA Invatec: Translating Global Success in Vascular Devices to the US Market Experience With Thoracic Endovascular Aortic Endovascular repair of Abdominal Aortic Aneurysm